Resultats de la cerca - Eric Sheldon

  • Mostrar 1 - 13 resultats de 13
Refinar resultats
  1. 1
    Lidocaine patch 5% improves pain, stiffness, and physical function in osteoarthritis pain patients

    Lidocaine patch 5% improves pain, stiffness, and physical function in osteoarthritis pain patients per Francis X. Burch, C. Codding, Nachiket Patel, Eric Sheldon

    Publicat 2004
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Effect of a natural extract of chicken combs with a high content of hyaluronic acid (Hyal-Joint®) on pain relief and quality of life in subjects with knee osteoarthritis: a pilot randomized double-blind placebo-controlled trial

    Effect of a natural extract of chicken combs with a high content of hyaluronic acid (Hyal-Joint®) on pain relief and quality of life in subjects with knee osteoarthritis: a pilot r... per Douglas Kalman, Maria Heimer, Anita Valdeon, Howard Schwartz, Eric Sheldon

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Randomized, double-blind, active-controlled study evaluating the safety and immunogenicity of three vaccination schedules and two dose levels of AV7909 vaccine for anthrax post-exposure prophylaxis in healthy adults

    Randomized, double-blind, active-controlled study evaluating the safety and immunogenicity of three vaccination schedules and two dose levels of AV7909 vaccine for anthrax post-exp... per Robert J. Hopkins, Gurdyal Kalsi, Victor Montalvo‐Lugo, Mona Sharma, Yukun Wu, Derek Muse, Eric Sheldon, Frank C. Hampel, Laurence Lemiale

    Publicat 2016
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Safety and Long-term Humoral Immune Response in Adults After Vaccination With an H1N1 2009 Pandemic Influenza Vaccine With or Without AS03 Adjuvant

    Safety and Long-term Humoral Immune Response in Adults After Vaccination With an H1N1 2009 Pandemic Influenza Vaccine With or Without AS03 Adjuvant per Murdo Ferguson, George Risi, Matthew Davis, Eric Sheldon, Mira Baron, Ping Li, Miguel G. Madariaga, Louis Fries, Olivier Godeaux, David W. Vaughn

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    A phase 1a, first-in-human, randomized study of a respiratory syncytial virus F protein vaccine with and without a toll-like receptor-4 agonist and stable emulsion adjuvant

    A phase 1a, first-in-human, randomized study of a respiratory syncytial virus F protein vaccine with and without a toll-like receptor-4 agonist and stable emulsion adjuvant per Judith Falloon, Fei Ji, Craig Curtis, Stephan Bart, Eric Sheldon, Diane Krieger, Filip Dubovsky, Stacie Lambert, Therese Takas, Tonya Villafana, Mark T. Esser

    Publicat 2016
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Randomized, double-blind, placebo-controlled, safety and immunogenicity study of 4 formulations of Anthrax Vaccine Adsorbed plus CPG 7909 (AV7909) in healthy adult volunteers

    Randomized, double-blind, placebo-controlled, safety and immunogenicity study of 4 formulations of Anthrax Vaccine Adsorbed plus CPG 7909 (AV7909) in healthy adult volunteers per Robert J. Hopkins, Nancy F. Daczkowski, Paulina E. Kaptur, Derek Muse, Eric Sheldon, Craig LaForce, Suha Sari, Thomas L. Rudge, Edward W. Bernton

    Publicat 2013
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Safety and Cross‐Reactive Immunogenicity of Candidate AS03‐Adjuvanted Prepandemic H5N1 Influenza Vaccines: A Randomized Controlled Phase 1/2 Trial in Adults

    Safety and Cross‐Reactive Immunogenicity of Candidate AS03‐Adjuvanted Prepandemic H5N1 Influenza Vaccines: A Randomized Controlled Phase 1/2 Trial in Adults per Joanne M. Langley, Louise Frenette, Linda Ferguson, Dennis Riff, Eric Sheldon, George Risi, Casey Johnson, Ping Li, Richard T. Kenney, Bruce L. Innis, Louis Fries

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study

    Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study per Robert W. Frenck, C. Buddy Creech, Eric Sheldon, David Seiden, Martin Kankam, James Baber, Edward T. Zito, Robin Hubler, Joseph Eiden, Joseph M. Severs, Shite Sebastian, Jasdeep S. Nanra, Kathrin U. Jansen, William C. Gruber, Annaliesa S. Anderson, Douglas Girgenti

    Publicat 2016
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years

    Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial i... per Dorothee Kieninger, Eric Sheldon, Wen‐Yuan Lin, Chong‐Jen Yu, José M. Bayas, Julian Gabor, Meral Esen, Jose Luis Fernandez Roure, Silvia Narejos Pérez, Carmen Alvarez Sanchez, Yang Feng, Carine Claeys, Mathieu Peeters, Bruce L. Innis, Varsha Jain

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Dose-Sparing H5N1 A/Indonesia/05/2005 Pre-pandemic Influenza Vaccine in Adults and Elderly Adults: A Phase III, Placebo-Controlled, Randomized Study

    Dose-Sparing H5N1 A/Indonesia/05/2005 Pre-pandemic Influenza Vaccine in Adults and Elderly Adults: A Phase III, Placebo-Controlled, Randomized Study per Joanne M. Langley, George Risi, Michael S. Caldwell, Larry Gilderman, Bruce Berwald, Charles Fogarty, Terry L. Poling, Dennis Riff, Mira Baron, Louise Frenette, Eric Sheldon, Harry Collins, Marc Shepard, Marc Dionne, Daniel Brüne, Linda Ferguson, David W. Vaughn, Ping Li, Louis Fries

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trial

    Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trial per C. Buddy Creech, Robert W. Frenck, Eric Sheldon, David Seiden, Martin Kankam, Edward T. Zito, Douglas Girgenti, Joseph M. Severs, Frederick W. Immermann, Lisa K. McNeil, David Cooper, Kathrin U. Jansen, William C. Gruber, Joseph Eiden, Annaliesa S. Anderson, James Baber

    Publicat 2016
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1)

    A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1) per Suresh S. Ramalingam, Glenwood Goss, Rafael Rosell, Gerald Schmid‐Bindert, Bojan Zarić, Z. Andric, Igor Bondarenko, Д. В. Комов, Timur Cerić, Fadlo R. Khuri, Miroslav Samaržija, Enriqueta Felip, Tudor‐Eliade Ciuleanu, Vera Hirsh, S. Cindy, James Spicer, Ravi Salgia, Geoffrey I. Shapiro, Eric Sheldon, Florentina Teofilovici, Vojo Vukovic, Dean A. Fennell

    Publicat 2015
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study

    Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-respons... per D. Gray Heppner, Tracy Kemp, Brian K. Martin, W. Jay Ramsey, Richard Nichols, Emily J. Dasen, Charles J. Link, Rituparna Das, Zhi Jin Xu, Eric Sheldon, Teresa Nowak, Thomas P. Monath, DG Heppner, TL Kemp, B R Martin, WJ Ramsey, Richard Nichols, EJ Dasen, Joan Fusco, Joseph Crowell, Charles Link, J Creager, TP Monath, Rituparna Das, ZJ Xu, Ronald Klein, Tristan Nowak, Eric Gerstenberger, Robin Bliss, EA Sheldon, Ricardo A. Feldman, Brandon Essink, W. Bradford Smith, Laurence Chu, WM Seger, Jamshid Saleh, JL Borders, Malcolm Adams

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: